RecruitingPhase 3NCT04664634
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
Sponsor
Northwestern University
Enrollment
60 participants
Start Date
Apr 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is the development and early-stage validation of a wearable sensor for dysphagia in patients with PD.
Eligibility
Min Age: 22 Years
Inclusion Criteria1
- Mild to moderate sialorrhea defined as a score of ≥ 11\* on the Radboud Oral Motor Inventory for Parkinson's Disease (ROMP)-Saliva (C) subscale Subjects must be in the "on" phase of their medication during all study assessments. The "on" phase is defined as the period when the participant's medication is at peak effectiveness, minimizing motor fluctuations and enabling optimal motor function.
Exclusion Criteria1
- Known allergy to contrast material used during MBSS. Known allergy to sensor adhesive. Indwelling tracheostomy tube. Nasogastric (NG) feeding tube. Currently pregnant.
Interventions
DEVICEAria Sensor
The Aria sensor is a wearable patch that continuously monitors physiological signals and provides vibratory haptic cues to increase swallow frequency. The intervention consists of using the sensor over a 3-week period, with active haptic cueing during Week 2 only.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04664634
Related Trials
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT0447778550 locations
Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease
NCT065060581 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
NCT066929201 location
[18F]F-DOPA Imaging in Patients With Autonomic Failure
NCT042464371 location